Articles in section Licensing
| << Joint Venture | 543 articles | Mergers & Acquisitions >> |
| Pages 1 2 3 4 5 .. 55 | Next >> |
-
Innovent Signs US$1.1B Licensing Alliance with Spero for IBI355 (SP001), for the Teatment Immune-Mediated Diseases
-
AstraZeneca Signs US$2.1 B Respiratory Disease Licensing Agreement with Sino Biopharmaceutical for TQC3721
-
Madrigal Pharmaceuticals Inks US$1 B pact with Arrowhead Pharmaceuticals to Advance RNAi Therapy for MASH
-
Madrigal Pharmaceuticals Strikes Global Licensing Pact with Suzhou Ribo Life Science to Advance siRNA Metabolic Programmes
-
Madrigal Inks US$50 M Deal with Pfizer for DGAT-2 inhibitor Ervogastat for the Treatment of MASH
-
Pfizer Secures US$2.09 B Licensing Agreement for YaoPharma’s Weight Management Candidate
-
Gilead’s Kite Signs US$1.64 B In Vivo CAR-T Deal with Pregene Biopharma
-
Novo Nordisk Expands Rare Disease Pipeline with US$2.4 B Omeros Partnership
-
AbbVie Signs US$1.225 B Licensing Pact with IGI Therapeutics for Oncology and Autoimmune Disease Treatment
-
Gilead Sciences Inks US$750 M Deal with Kymera Therapeutics for Novel Oral Molecular Glue CDK2 Degraders
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
RSS